Chris Carpenter joins the R&D exodus out of pharma; George Church's eGenesis selects Jodie Morrison as new CEO
⇨ After spending the last decade in Big Pharma R&D, Chris Carpenter is making the leap to biotech, joining the rising star …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
